The Valley Desk

ArticleJournal of the American Medical Directors AssociationPublished

Public Health Impact of Adjuvanted RSVPreF3 Vaccination Among US Adults Aged ≥60 Years Residing in Long-Term Care Settings

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names GSK. Affiliation source

Institution
GSK

Publication record

Type
Article
Venue
Journal of the American Medical Directors Association
Published
Subject terms
Humans; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus Vaccines; Adjuvants, Immunologic; Long-Term Care; Markov Chains; Public Health; Aged; Aged, 80 and over; Middle Aged; Nursing Homes; United States
PubMed ID
42896317
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal